Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2022

Stockholders' Equity

Schedule of fair value of stock option awards valuation assumptions

		Weighted		Weighted
		Average		Average	Aggregate
	Number of	Exercise		Remaining	Intrinsic
	Shares	Price		Term	Value
Balance as of December 31, 2021	4,560	$	6.29	3.07	$	2,670
Granted	593		4.33
Exercised	(308)		1.02
Forfeited	(83)		6.48
Expired	(407)		7.38
Balance as of March 31, 2022	4,355		6.29	4.03		1,766
Expected to vest at March 31, 2022	4,355		6.29	4.03		1,766
Exercisable at March 31, 2022	3,274		6.18	2.38		1,261

Schedule of the restricted stock unit activity

		Weighted Average Grant-
	Shares	Date Fair Value
Outstanding as of December 31, 2021	5,235	$	8.88
Granted	4,438		4.33
Vested	(167)		5.73
Forfeited	(32)		6.32
Outstanding as of March 31, 2022	9,474	$	6.82

Schedule of Stock-Based Compensation Expense

	Three Months Ended March 31,
	2022		2021
Cost of revenue, excluding depreciation and amortization	$	460	$	42
Sales and marketing		722		29
General and administrative		2,598		54
Research and development		160		13
Total	$	3,940	$	138